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Nasopharyngeal carcinoma (NPC) is a biologically distinct form
of head and neck cancer occurring more frequently in Oriental
population than in whites. It is a unique head and neck cancer
because of its epidemiology, association with Epstein–Barr virus
and biological behaviour (Roychowdhury et al, 1996). The tumour
is known to grow rapidly and is highly metastatic. Histologically,
these tumours are classified by WHO into three types as squamous
cell carcinoma, non-keratinizing and undifferentiated carcinoma
(Shanmugaratnam et al, 1979), with the predominant histological
type being poorly or undifferentiated carcinoma (Lo et al, 1992).
In an effort to understand the biology of this intriguing tumour,
various biomarkers such as oncogenes, p53 tumour suppressor
gene, waf1 protein, proliferating cell nuclear antigen (PCNA),
telomerase, microsatellite markers and cytogenetic changes have
been examined (Lo et al, 1992; Kouvidou et al, 1997; Oh and Mao,
1997). One biomarker which has recently been shown to be
expressed in various human tumours but hitherto still unreported
in NPC is metallothionein (MT). MTs are cysteine rich intracel-
lular metal binding proteins that are present in a wide variety of
eukaryotes (Kagi and Schaffer, 1988). Functioning as antioxi-
dants, they also have a protective role against hydroxyl free radi-
cals (Lazo and Pitt, 1995). This is especially relevant in NPC, a
tumour known to be markedly radiosensitive and where radio-
therapy (which kills cells via free-radical-induced apoptosis) is the
treatment of choice (Bailet et al, 1992; Meyn et al, 1996).
In light of the above findings, we decided to (a) examine the
level of MT expression by immunohistochemistry and its precise
localization at the ultrastructural level by immunoelectron
microscopy, (b) analyse the apoptotic index by terminal deoxy
nucleotidyl transferase (TdT)-mediated dUTP biotin nick end
labelling (TUNEL method) and (c) explore the relationship
between MT expression and apoptosis in NPC tissues.
MATERIALS AND METHODS
Materials and patients
Twenty-one nasopharyngeal biopsies randomly selected from Tan
Tock Seng Hospital and Singapore General Hospital were
included in this study. Seventeen cases were confirmed to be
undifferentiated carcinoma (WHO Type 3), whereas four biopsies
showed normal histology of the nasopharynx. The tumour tissues
were obtained from 15 men (12 Chinese, two Malay, one Thai) and
two Chinese women with a mean age of 53 years (range 33–81
years). The patients presented with ear symptoms such as
decreased hearing and tinnitus, nasal symptoms such as nasal
discharge and epistaxis, respiratory symptoms such as blood-
stained phlegm and one presented with a neck lump. Forty-one per
cent of the cases (seven patients) already had cervical lymph node
enlargement at the time of diagnosis.
Methods
Immunohistochemistry
Sections were cut from paraffin-embedded tissues at a thickness of
4 mm and mounted on APES (3-aminopropyl-tri-ethoxy silane;
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using the avidin–biotin complex technique (Zelger et al, 1993).
Briefly, sections were incubated overnight at 4°C using 1:600
dilution of primary antibody E9 (Dako, Copenhagen, Denmark), a
conserved epitope directed against MT I and MT II isoforms,
followed by incubation with the secondary antibody (biotinylated
rabbit anti-mouse immunoglobulin; Dako) at 1:200 dilution for 
1 h. After a 1-h incubation with biotin and avidin–peroxidase
complexes, immunostaining was demonstrated using 3,3´ dia-
minobenzidine tetrachloride (DAB). After immunostaining,
sections were counterstained with Harris haematoxylin for 15 s,
dehydrated, cleared in xylene and mounted with permount. For
negative controls, tissue sections were incubated with mouse
immunoglobulin of the same sub-class. For positive controls,
sections from an MT positive breast cancer was used (Jin et al,
1999).
Analysis of immunohistochemical reactions
For assessing the percentage of positively stained cells, sections
were analysed under a light microscope (Zeiss, Axioplan) using a
40´ objective. The number of positive cells per high power field
was determined in relation to the total number of cells in that field.
A total of ten high power fields were randomly chosen. The rela-
tive intensity of staining was assessed subjectively by two
members of the group. The immunohistochemical staining was
graded as ‘+’ for weak staining, ‘++’ for moderate staining and
‘+++’ for strong staining. To study the correlation between the
percentage of MT-positive cells and staining intensity, a numerical
scoring was also instituted for staining intensity: 1 for ‘+’, 2 for
‘++’ and 3 for ‘+++’.
Transmission electron microscopy and immunoelectron
microscopy
Tissue from a confirmed undifferentiated NPC (by light micro-
scopy) was fixed in 3% glutaraldehyde and 2% paraformaldehyde
before osmication in 2% osmium tetroxide as previously described
(Bay et al, 1998). Post-osmicated samples were dehydrated in an
ascending series of ethanol and embedded in epoxy resin.
Ultrathin sections for immunolabelling and conventional electron
microscopy were cut and mounted on formvar-coated nickel grids.
For unmasking of antigens, the procedure of Stirling and Graff
(1995) was followed. Briefly, grids for immunolabelling were
incubated on large drops of saturated aqueous solution of sodium
metaperiodate for 1 h at room temperature (RT) in a humidified
chamber followed by washing in distilled water for 45–60 s. The
grids were then heated by floating them sections down in
preheated 0.01 M sodium citrate buffer (pH 6) maintained at
95–100°C for 10 min. The sections were allowed to cool in the
retrieval medium for 15 min followed by washing in distilled
water for 60 s. After antigen unmasking treatment, grids were first
incubated on 0.01 M phosphate-buffered saline (PBS) pH 7.4
containing 1% immunoglobulin-free bovine serum albumin (BSA)
for 10 min. Sections were then incubated overnight (18 h) at 4°C
with the E9 primary antibody at a dilution of 1:100 in PBS
containing 1% BSA and 1% Tween-20. The grids were washed by
floating them on drops of PBS (3 changes, 5 min each), followed
by 5-min incubation on PBS with 1% BSA. Bound antibodies
were visualized by incubating the sections for 1 h on EM goat anti-
mouse immunoglobulin gold conjugate (20 nm) diluted 1:100 in
PBS with 1% BSA and 1% Tween-20 at RT before washing with
water (3 changes, 5 min each). The grids were then stained with
1% aqueous uranyl acetate and lead citrate. The sections were
examined in Philips 120 EM transmission electron microscope.
Immunogold specificity was tested by omitting the primary anti-
body and incubating the sections with antibody diluent.
In situ detection of apoptotic cells in paraffin sections
(TUNEL method)
Apoptotic cells in formalin-fixed and paraffin-embedded tissue
sections were detected by the commercially available Tdt Frag
ELtm DNA Fragmentation Detection kit (Oncogene Research
Products, Cambridge, MA, USA). Briefly paraffin sections were
dewaxed in xylene and rehydrated in alchohol, followed by
incubation with proteinase k (20 mg ml–1) at RT for 20 min.
Endogenous peroxidase activity was blocked by incubating the
slides in 3% hydrogen peroxide. Following the application of the
equilibration buffer, the sections were incubated in working
strength TdT enzymes (containing dUTP–digoxigenin) at 37°C
for 90 min. The reaction was stopped by a prewarmed working
strength stop buffer. After washing in distilled water an anti-digox-
igenin antibody fragment carrying enzyme peroxidase was applied
in a humidified chamber for 30 min at RT. The localized peroxi-
dase enzyme catalytically generated an intense signal from the
chromogenic DAB substrate. The sections were counterstained
with methyl green. Quantitative evaluation of positive apoptotic
cells was done by examining the sections in ten random regions
and counting the number of TUNEL-positive cancer cells among
1000 carcinoma cells using the Zeiss Axioplan microscope. The
apoptotic index was expressed as positive cells per 100 cancer
cells.
Statistical analyses
The Graphpad Prism software package was used for statistical
analysis. The relationship between the percentage of MT-
immunostained cells and cervical lymph node status was analysed
by c2 test. Pearson’s correlation was used to analyse the relation-
ship between the percentage of MT-positive cells with age,
staining intensity and apoptosis.
RESULTS
MT immunohistochemistry
MT-immunopositivity was detected in all the 17 NPC tissue
sections examined. An example of an undifferentiated NPC tissue
section (Figure 1A) exhibiting high levels of MT expression is
shown in Figure 1B. MT staining was localized to the nucleus and
absent in the cytoplasm. Generally, in sections with high MT-
immunopositivity, the immunopositive cells formed contiguous
foci or sheets. In sections with low MT immunoreactivity, scat-
tered positive cells predominate and on some occasions isolated
clusters of positive cells were seen. The four tissues with normal
histology of the nasopharynx showed MT staining in the inner
layer of the epithelium, the germinal centers and the lining
vascular endothelium.
The percentage of MT-immunopositive tumour cells determined
under light microscopy ranged from 3% to 57.9% (Table 1). In
nine of the 17 cases, the tumour sections exhibited more than 10%
MT-immunopositivity. With regard to staining intensity, tumour
sections with weakly stained cells formed the largest group (47%).
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MT-positive cells and the intensity of MT staining (Figure 2;
P < 0.001, Pearson’s r = 0.95). The percentage of MT-immuno-
positive cells was found to be directly proportional to the intensity
of the immunostain. Tumour sections exhibiting less than 10%
MT-immunopositivity were all weakly stained whereas those with
more than 32% immunopositivity (except for case 7) were
strongly stained.
There was no correlation between the percentage of
immunopositive cells and age of patients (P = 0.93). There was
also no association between the percentage of MT-immunoposi-
tive cells (subdivided into two groups: > 10% and < 10% MT-
immunopositive cells) and the cervical lymph node status (P =
0.20).
Ultrastructural localization of MT
Under transmission electron microscopy, the cancer cells are char-
acterized by the presence of (a) desmosomes (macula adherens),
which are specialized junctional membranes at the contiguous
border of adjacent tumour cells, (b) abundant tonofilaments
(keratin fibrils) in the cytoplasm and (c) large nuclei (with high
nucleocytoplasmic ratio) bounded by a nuclear membrane with
undulating margins (Figure 3A). The MT protein was localized
essentially in the nucleoplasm of the tumour cell nuclei rather than
in the nuclear membrane or cytoplasm (Figure 3B).
Apoptosis
The apoptotic index ranged from 0.1 to 1.8 cells per 100 cancer
cells (Table 1). An example of apoptotic cells in a tumour section
is shown in Figure 1C. The percentage of MT-immunopositive
cells was found to be inversely proportional to the apoptotic rate
(Figure 4; P < 0.001, Pearsons r = –0.6380).
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Figure 1 (A) Undifferentiated nasopharyngeal carcinoma stained with
haematoxylin and eosin (original magnification 210 ´). (B) Nasopharyngeal
tumour section immunostained with monoclonal mouse anti-metallothionein
E9 antibody (haematoxylin, original magnification 390 ´). (C) Apoptotic cells
(brown nuclei) in a tumour section labelled by TUNEL method (methyl green,
original magnification 500 ´)
Table 1 Metallothoinein immunoreactivity and corresponding apoptotic
rates in nasopharyngeal cancers
Patient MT MT Apoptotic
immunoreactivity staining intensity index
(% stained cells) (positive cells/100
cancer cells)
1 57.2 +++ 0.3
2 43.5 +++ 0.2
3 57.9 +++ 0.1
4 23.8 ++ 0.4
5 18.3 ++ 0.3
6 32.4 +++ 0.5
7 33.4 ++ 0.6
8 5.5 + 0.8
9 5.0 + 1.0
10 5.3 + 0.7
11 4.6 + 1.0
12 3.8 + 1.8
13 4.1 + 0.6
14 3.0 + 0.5
15 3.4 + 0.7
16 8.6 + 0.6
17 4.9 + 0.7Metallothionein expression and apoptosis in nasopharyngeal cancer 1201
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DISCUSSION
It is well established that MT, a superfamily of metal-binding
macromolecules, participates in sulphur-based metal clusters
(Kagi and Schaffer, 1988). In fact, a conspicuous feature of all the
different subclasses of mammalian MTs is the presence of cysteine
residues which have the capability to bind metals. Consequently,
MTs have metalloregulatory functions in cell growth and differen-
tiation (Cherian et al, 1994). The ubiquitous occurrence of MT and
the conservation of its structure further suggests that besides
having a specific role in normal cellular metabolism, MTs may be
involved pleiotropically in a plethora of different biological func-
tions (Kagi and Schaffer, 1988).
Since MT is known to possess antioxidant properties which
protect cells from free radical-induced apoptosis (Lazo and Pitt,
1995), its possible role in carcinogenesis has attracted attention in
recent years. Amongst others, overexpression of MT has been
reported in testicular tumours (Kontozoglou et al, 1989), bladder
carcinomas (Bahnson et al, 1991), ovarian tumours (Germain et al,
1996; Tan et al, 1999), malignant melanoma (Zelger et al, 1993)
and invasive breast cancers (Schmid et al, 1993; Jin et al, 1999). In
tumours such as ductal breast cancer and malignant melanoma,
MT expression is associated with more malignant and higher
grade tumours. In head and neck cancers, MT expression in squa-
mous cell carcinoma of the tongue has been suggested to delay
cells entering apoptosis (Sundelin et al, 1997). The present study is
the first to document the overexpression of MT in NPC. All the
tumour specimens exhibited MT-immunopositivity and tumour
sections with higher percentages of MT-immunopositive cells
showed more intense staining. The methodology for detecting MT
protein includes Western blotting, electrophoresis followed by
silver staining and immunohistochemistry (Aoki and Suzuki,
1991; McCormick and Lin, 1991; Zelger et al, 1993). We chose to
investigate MT expression in NPC by immunohistochemical
staining as immunohistochemical detection has the advantage of
correlating MT protein expression with the pathology of the
tumour.
The MT immunoreactivity was found to be mainly localized to
the nucleus, in particular the nucleoplasm. It is possible for the MT
protein to diffuse through the nuclear pore complex either by
passive diffusion or via an active, signal-mediated process (Woo et
al, 1996). Another possible reason for the preferential localization
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Figure 2 Positive correlation between MT-immunopositive cells (expressed
as percentage of stained cells) with the staining intensity (r = 0.95,
r2 = 0.9025, P < 0.001) A
B
Figure 3 (A) Transmission electron micrograph of NPC cells typified by
desmosomes (arrows) and tonofilaments (arrowheads). A lymphocyte (L) is
seen in the vicinity (original magnification, 7260 ´). Scale bar = 1 mm.
(B) Immunogold particles localized mainly in the nucleoplasm of tumour cell
nucleus (N) and not in the cytoplasm (C) (original magnification, 40 700 ´).
Scale bar = 100 nm
Figure 4 Inverse relationship between MT immunopositive cells (expressed
as percentage of stained cells) with the apoptotic index (r = –0.6380; 
2 = 0.4070; P = 0.0059)
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)of MT in the nucleus could be the interaction of MT with zinc ions
(Jin et al, 1999), which are known to be raised in NPC (Bay et al,
1997). Since the nuclear phenotype has been reported in human
malignancies typified by rapid growth (Woo et al, 1996), such as
bladder tumour cells (Kuo et al 1994), it is also possible that over-
expression of MT in the nuclei of NPC cells is related to high
proliferative activity.
Antioxidants are known to restrict the apoptotic process in
many systems (Briehl and Baker, 1996). In this regard, modulation
of the cellular antioxidant defence would have far reaching effects
on tumour response to apoptotic stimuli although reports have
been varied. Down-regulation of MT with increased apoptosis has
been observed in hepatocellular carcinoma (Cai et al, 1998),
whereas increased incidence of apoptosis with increasing
immunoreactivity of MT has been reported in renal cell carcinoma
(Zhang and Takenaka, 1998). In the present study, we found an
inverse correlation in tumour cells exhibiting high MT expression
and the rate of apoptosis. Our results appear to indicate that MT
overexpression may contribute to the rapid growth of these
tumours by retarding apoptosis.
In addition, support for the hypothesis that MTs participate in
intracellular defence against reactive oxygen species is derived
from the observation that MT genes are transcriptionally activated
in cells and tissues during oxidative stress (Lazo and Pitt, 1995).
Endogenous antioxidants are known to protect cells from reactive
oxygen species mediated DNA damage (occurring in the nucleus)
as a result of radiation (Buttke and Sandstorm, 1994). Hence, the
radioprotective effect of MT against DNA damage by free radicals
is likely to be enhanced by nuclear sequestration. The demonstra-
tion of nuclear localization of MT would certainly not augur well
for NPC patients who have a high percentage of MT-positive
tumour cells. Besides protecting the cell against apoptosis, the
abundant nucleophilic sulphydryl groups in MT could interact
with many electrophilic toxins, thereby making them attractive
candidates as modulators of cellular senstivity to electrophilic
anticancer agents. In fact, induction of MT has also been
suggested to be an important mechanism in potentiating the resis-
tance of tumour cells to chemotherapeutic agents (Kelley et al,
1988).
In conclusion, we have demonstrated that MT is overexpressed
in NPC by immunohistochemical staining. The unique features of
the immunostaining are: (a) preferential localization of MT in the
nucleus, (b) a positive correlation between the percentage of MT
immunopositive cells and the intensity of staining, (c) an inverse
correlation between MT expression and apoptosis favouring the
hypothesis that MT protects the tumour cells from undergoing
apoptosis and contributes to tumour expansion. Furthermore, up-
regulation of MT in NPC tissues may indeed be important in the
development of radioresistance in NPC. To elucidate whether the
immunohistochemical observation of MT overexpression can be
used as a marker of radioresistance in nasopharyngeal cancers, a
prospective investigation entailing the retrospective analysis of
archival material from NPC patients, will be carried out.
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